Literature DB >> 14760767

Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

Laszlo Lakatos1, Gabor Mester, Zsuzsanna Erdelyi, Mihaly Balogh, Istvan Szipocs, Gyorgy Kamaras, Peter Laszlo Lakatos.   

Abstract

AIM: An investigation into inflammatory bowel disease and colorectal cancer in Veszprem Province was conducted from 1977 to 2001.
METHODS: Both hospital and outpatient records were collected and reviewed comprehensively. The majority of patients were followed up regularly.
RESULTS: The population of the province was decreased from 386,000 to 376,000 during the period. Five hundred sixty new cases of ulcerative colitis (UC), 212 of Crohn's disease (CD), and 40 of indeterminate colitis (IC) were diagnosed. The incidence rates increased from 1.66 to 11.01 cases per 100,000 persons for UC, from 0.41 to 4.68 for CD and from 0.26 to 0.74 for IC. The prevalence rate at the end of 2001 was 142.6 for UC and 52.9 cases per 100,000 persons for CD. The peak onset age in UC patients was between 30 and 40 years, in CD between 20 and 30 years. A family history of IBD was present in 3.4 % in UC and 9.9 % in CD patients. Smoking increased the risk for CD (OR=1.98) while it decreased the risk for UC (OR=0.25). Twelve colorectal carcinomas were observed in this cohort, the cumulative colorectal cancer risk after 10 years in UC was 2%, after 20 years 8.8%, after 30 years 13.3%.
CONCLUSION: The incidence and prevalence rates of IBD have increased steadily in Veszprem Province, now equivalent to that in Western European countries. Rapid increase in incidence rates supports a probable role for environmental factors. The rate of colorectal cancers in IBD is similar to that observed in Western countries.

Entities:  

Mesh:

Year:  2004        PMID: 14760767      PMCID: PMC4724919          DOI: 10.3748/wjg.v10.i3.404

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  Screening and surveillance colonoscopy in chronic Crohn's colitis.

Authors:  S Friedman; P H Rubin; C Bodian; E Goldstein; N Harpaz; D H Present
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

3.  Exposure to risk factors for ulcerative colitis occurs during an early period of life.

Authors:  F Delcò; A Sonnenberg
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

4.  Epidemiology of Crohn's disease in Israel: a survey of Israeli kibbutz settlements.

Authors:  Y Niv; G Abuksis; G M Fraser
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

5.  Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study.

Authors:  T Gilat; D Hacohen; P Lilos; M J Langman
Journal:  Scand J Gastroenterol       Date:  1987-10       Impact factor: 2.423

Review 6.  Genetics of inflammatory bowel diseases--past, present, and future.

Authors:  A S Peña
Journal:  Dig Dis       Date:  2003       Impact factor: 2.404

7.  Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study.

Authors:  Subra Kugathasan; Robert H Judd; Raymond G Hoffmann; Janice Heikenen; Gregorz Telega; Farhat Khan; Sally Weisdorf-Schindele; William San Pablo; Jean Perrault; Roger Park; Michael Yaffe; Christopher Brown; Maria T Rivera-Bennett; Issam Halabi; Alfonso Martinez; Ellen Blank; Steven L Werlin; Colin D Rudolph; David G Binion
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

8.  Hla-B genotype in Japanese patients with Crohn's disease.

Authors:  Yoshitaka Kinouchi; Keisuke Matsumoto; Kenichi Negoro; Sho Takagi; Seiichi Takahashi; Nobuo Hiwatashi; Tooru Shimosegawa
Journal:  Dis Colon Rectum       Date:  2003-10       Impact factor: 4.585

9.  Incidence of colorectal cancer in proctocolitis: a retrospective study of 959 cases over 40 years.

Authors:  Z Maratka; J Nedbal; J Kociánová; J Havelka; J Kudrmann; J Hendl
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

10.  Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population.

Authors:  K Hata; T Watanabe; S Kazama; K Suzuki; M Shinozaki; T Yokoyama; K Matsuda; T Muto; H Nagawa
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

View more
  39 in total

1.  Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Authors:  Eun Soo Kim; Won Ho Kim
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

2.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

Review 3.  Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

Authors:  Andrea Michielan; Renata D'Incà
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 4.  Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?

Authors:  L Lakatos; P L Lakatos
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

Review 5.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 6.  Smoking in inflammatory bowel diseases: good, bad or ugly?

Authors:  Peter Laszlo Lakatos; Tamas Szamosi; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

7.  The 3'UTR NFKBIA variant is associated with extensive colitis in Hungarian IBD patients.

Authors:  Tamas Szamosi; Peter Laszlo Lakatos; Aniko Szilvasi; Laszlo Lakatos; Agota Kovacs; Tamas Molnar; Istvan Altorjay; Maria Papp; Orsolya Szabo; Anna Satori; Zsolt Tulassay; Pal Miheller; Henrik Csaba Horvath; Janos Papp; Attila Tordai; Hajnalka Andrikovics
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

8.  NOD2 gene mutations in ulcerative colitis: useless or misunderstood?

Authors:  Paulo Freire; Ricardo Cardoso; Pedro Figueiredo; Maria M Donato; Manuela Ferreira; Sofia Mendes; Ana Margarida Ferreira; Helena Vasconcelos; Francisco Portela; Carlos Sofia
Journal:  Int J Colorectal Dis       Date:  2014-03-22       Impact factor: 2.571

9.  Is early limited surgery associated with a more benign disease course in Crohn's disease?

Authors:  Petra Anna Golovics; Laszlo Lakatos; Attila Nagy; Tunde Pandur; Istvan Szita; Mihaly Balogh; Csaba Molnar; Erzsebet Komaromi; Barbara Dorottya Lovasz; Michael Mandel; Gabor Veres; Lajos S Kiss; Zsuzsanna Vegh; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

10.  Branched Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) Protect against Colitis by Regulating Gut Innate and Adaptive Immune Responses.

Authors:  Jennifer Lee; Pedro M Moraes-Vieira; Angela Castoldi; Pratik Aryal; Eric U Yee; Christopher Vickers; Oren Parnas; Cynthia J Donaldson; Alan Saghatelian; Barbara B Kahn
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.